Journal article
Use of tramadol to attenuate severe dyskinesia in anti-N-methyl-D-aspartate receptor encephalitis
Anaesthesia and Intensive Care, Vol.47(6), pp.561-562
2019
Abstract
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is mediated by antibodies against the NMDA receptor in the cerebrospinal fluid and characterised by a complex neuropsychiatric syndrome.(1)
Details
- Title
- Use of tramadol to attenuate severe dyskinesia in anti-N-methyl-D-aspartate receptor encephalitis
- Authors/Creators
- K.M. Ho (Author/Creator) - Royal Perth Hospital
- Publication Details
- Anaesthesia and Intensive Care, Vol.47(6), pp.561-562
- Publisher
- Australian Society of Anaesthetists
- Identifiers
- 991005543836007891
- Copyright
- © 2020 by Australian Society of Anaesthetists
- Murdoch Affiliation
- School of Veterinary and Life Sciences
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
31 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.203 Neuromuscular Disorders
- 1.203.1602 Limbic Encephalitis
- Web Of Science research areas
- Anesthesiology
- Critical Care Medicine
- ESI research areas
- Clinical Medicine